DHR
Danaher Corporation Healthcare - Life Sciences Investor Relations →
Danaher Corporation (DHR) closed at $200.14 as of 2026-09-11, trading 8.6% below its 200-week moving average of $218.89. This places DHR in the deep value zone. The stock is currently moving closer to the line, down from -5.2% last week. The 14-week RSI sits at 58, indicating neutral momentum.
Trading volume is running at 0.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.97 ratio) is neutral — neither side is clearly dominating.
Over the past 2441 weeks of data, DHR has crossed below its 200-week moving average 15 times. On average, these episodes lasted 21 weeks. Historically, investors who bought DHR at the start of these episodes saw an average one-year return of +17.9%.
With a market cap of $140.7 billion, DHR is a large-cap stock. The company generates a free cash flow yield of 3.1%. Return on equity stands at 7.6%. The stock trades at 2.7x book value.
Over the past 33.8 years, a hypothetical investment of $100 in DHR would have grown to $29874, compared to $3170 for the S&P 500. That represents an annualized return of 18.4% vs 10.8% for the index — confirming DHR as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been declining at a -10.8% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: DHR vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After DHR Crosses Below the Line?
Across 10 historical episodes, buying DHR when it crossed below its 200-week moving average produced an average return of +21.0% after 12 months (median +24.0%), compared to +14.6% for the S&P 500 over the same periods. 89% of those episodes were profitable after one year. After 24 months, the average return was +36.8% vs +31.6% for the index.
Each line shows $100 invested at the moment DHR crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices DHR would reach each dislocation threshold.
Dislocation Price Levels
Prices where DHR's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-10-20.
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $171.59 | Unusually cheap — analysis point |
| Value | +1σ | $182.17 | Cheap vs. own history |
| Fair Value | +0σ | $194.15 | Historical mean behavior |
| Expensive | -1σ | $207.80 | Expensive vs. own history |
| Deep Expensive | -2σ | $223.53 | Unusually expensive — analysis point |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-21 | $1.84 | $1.94 | +5.3% |
| 2026-04-21 | $1.94 | $2.06 | +6.5% |
| 2026-01-28 | $2.19 | $2.23 | +2.0% |
| 2025-10-21 | $1.72 | $1.89 | +9.8% |
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from DHR's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
DHR has crossed below its 200-week MA 15 times with an average 1-year return of +17.9% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Dec 1979 | Aug 1980 | 33 | 35.8% | -18.9% | +355159.9% |
| Aug 1980 | Dec 1980 | 19 | 15.0% | +5.9% | +386504.6% |
| Aug 1981 | May 1983 | 91 | 47.2% | -47.2% | +365026.5% |
| Jul 1983 | Sep 1983 | 11 | 14.2% | +76.7% | +438052.7% |
| Oct 1990 | Nov 1990 | 1 | 1.5% | +31.0% | +56557.7% |
| Sep 2001 | Oct 2001 | 3 | 7.8% | +20.4% | +4298.9% |
| Sep 2002 | Sep 2002 | 2 | 2.7% | +34.9% | +3471.2% |
| Nov 2002 | Nov 2002 | 1 | 0.2% | +47.4% | +3444.5% |
| Sep 2008 | Oct 2009 | 54 | 26.8% | +3.6% | +1494.9% |
| Oct 2009 | Nov 2009 | 1 | 0.5% | +27.4% | +1361.1% |
| May 2023 | May 2023 | 2 | 1.6% | +26.3% | +1.1% |
| Jul 2023 | Jul 2023 | 1 | 0.6% | +16.3% | -1.5% |
| Oct 2023 | Nov 2023 | 6 | 12.7% | +29.6% | -2.9% |
| Nov 2024 | Dec 2025 | 58 | 23.6% | -3.4% | -12.2% |
| Jan 2026 | Ongoing | 33+ | 27.3% | Ongoing | -8.2% |
| Average | 21 | — | +17.9% | — |
Frequently Asked Questions
Is DHR below its 200-week moving average?
Yes. As of 2026-09-11, Danaher Corporation (DHR) is trading 8.6% below its 200-week moving average of $218.89. The current price is $200.14.
What is DHR's 200-week moving average price?
Danaher Corporation's 200-week moving average is $218.89 as of 2026-09-11. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when DHR drops below its 200-week moving average?
DHR has crossed below its 200-week moving average 15 times in our data. On average, buying at that moment produced a one-year return of +17.9%. These dips have historically been decent entry points. These episodes lasted 21 weeks on average.
Is DHR a good value right now?
Here's what our data says about DHR as of 2026-09-11: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 58. Free cash flow yield is 3.1%. Return on equity is 7.6%. Price-to-book is 2.7x. This is not a buy or sell recommendation — always do your own research.
How does DHR compare to the S&P 500?
Over the past 33.8 years, $100 invested in DHR would have grown to $29874, compared to $3170 for the S&P 500. That's 18.4% annualized vs 10.8% for the index. DHR has outperformed the broader market over this period.
Does DHR pay a dividend?
Yes. Danaher Corporation currently pays a dividend yield of 80.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-09-11